| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ESSA Pharma Inc (NASDAQ: EPIX)
EPIX Technical Analysis
5
| As on 25th Aug 2025 EPIX SHARE Price closed @ 0.78 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.91 & Strong Sell for SHORT-TERM with Stoploss of 7.53 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EPIXSHARE Price
| Open | 0.74 | Change | Price | % |
| High | 0.82 | 1 Day | -1.15 | -59.59 |
| Low | 0.73 | 1 Week | -1.14 | -59.38 |
| Close | 0.78 | 1 Month | -1.08 | -58.06 |
| Volume | 165549875 | 1 Year | -7.94 | -91.06 |
| 52 Week High 9.30 | 52 Week Low 1.40 | ||||
NASDAQ USA Most Active Stocks
| OPEN | 4.54 | -9.38% |
| AMRS | 0.14 | 100.00% |
| EPIX | 0.78 | -59.59% |
| NVDA | 179.81 | 1.02% |
| INTC | 24.55 | -1.01% |
| TLRY | 1.39 | 20.87% |
| LMDX | 0.02 | 0.00% |
| SGBX | 0.19 | 5.56% |
| AKTS | 0.04 | 0.00% |
| SOFI | 26.15 | 4.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| EPIX Daily Charts |
EPIX Intraday Charts |
Whats New @ Bazaartrend |
EPIX Free Analysis |
|
|
EPIX Important Levels Intraday
| RESISTANCE | 0.95 |
| RESISTANCE | 0.90 |
| RESISTANCE | 0.86 |
| RESISTANCE | 0.83 |
| SUPPORT | 0.73 |
| SUPPORT | 0.70 |
| SUPPORT | 0.66 |
| SUPPORT | 0.61 |
EPIX Forecast August 2025
| 4th UP Forecast | 6.5 |
| 3rd UP Forecast | 4.67 |
| 2nd UP Forecast | 3.53 |
| 1st UP Forecast | 2.4 |
| 1st DOWN Forecast | -0.84 |
| 2nd DOWN Forecast | -1.97 |
| 3rd DOWN Forecast | -3.11 |
| 4th DOWN Forecast | -4.94 |
EPIX Weekly Forecast
| 4th UP Forecast | 2.36 |
| 3rd UP Forecast | 1.85 |
| 2nd UP Forecast | 1.54 |
| 1st UP Forecast | 1.23 |
| 1st DOWN Forecast | 0.33 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | -0.29 |
| 4th DOWN Forecast | -0.80 |
EPIX Forecast2025
| 4th UP Forecast | 17.87 |
| 3rd UP Forecast | 12.39 |
| 2nd UP Forecast | 9 |
| 1st UP Forecast | 5.61 |
| 1st DOWN Forecast | -4.05 |
| 2nd DOWN Forecast | -7.44 |
| 3rd DOWN Forecast | -10.83 |
| 4th DOWN Forecast | -16.31 |
ESSA Pharma Inc ( NASDAQ USA Symbol : EPIX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EPIX Business Profile
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. ESSA Pharma Inc. has a collaboration with Caris Life Sciences, Inc. The company was founded in 2009 and is headquartered in Vancouver, Canada. Address: 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service